par Taillibert, Sophie;Voillery, Dorothée;Bernard, Chantal 
Référence Current opinion in oncology, 19, 6, page (623-627)
Publication Publié, 2007-11
Référence Current opinion in oncology, 19, 6, page (623-627)
Publication Publié, 2007-11
Article révisé par les pairs
| Résumé : | The existence of chemobrain has become almost universally accepted, although many details of the concept are controversial. Data about the different types of cognitive impairment and their duration are not always consistent in the literature. We still do not know which cytotoxic agents are responsible, which characteristics make patients vulnerable, and which biologic mechanisms are involved. |
